Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Process Automation and Control Strategy by Quality-by-Design in Total Continuous mRNA Manufacturing Platforms
A. Schmidt, Heribert Helgers, Florian Lukas Vetter, et al.
Processes (2022) Vol. 10, Iss. 9, pp. 1783-1783
Open Access | Times Cited: 20

Showing 20 citing articles:

Is it advantageous to use quality by design (QbD) to develop nanoparticle-based dosage forms for parenteral drug administration?
C Camacho Vieira, Leena Peltonen, Anssi-Pekka Karttunen, et al.
International Journal of Pharmaceutics (2024) Vol. 657, pp. 124163-124163
Open Access | Times Cited: 11
Membrane technology for the purification of RNA and DNA therapeutics
Amin Javidanbardan, Kevork Oliver Messerian, Andrew L. Zydney
Trends in biotechnology (2024) Vol. 42, Iss. 6, pp. 714-727
Closed Access | Times Cited: 9
Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches
Ravi Maharjan, Ki Hyun Kim, Kyeong Lee, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 11, pp. 100996-100996
Open Access | Times Cited: 7
Vaccine process technology—A decade of progress
Barry C. Buckland, Gautam Sanyal, Todd Ranheim, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 9, pp. 2604-2635
Open Access | Times Cited: 5
CMC Strategies and Advanced Technologies for Vaccine Development to Boost Acceleration and Pandemic Preparedness
Maria Monica Castellanos, Hervé Gressard, Xiangming Li, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1153-1153
Open Access | Times Cited: 14
Quality by Design (QbD) and Design of Experiments (DOE) as a Strategy for Tuning Lipid Nanoparticle Formulations for RNA Delivery
Lidia Gurba-Bryśkiewicz, Wioleta Maruszak, Damian Smuga, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2752-2752
Open Access | Times Cited: 14
Bioprocessing 4.0: A Pragmatic Review and Future Perspectives
Kesler Isoko, Joan Cordiner, Zoltán Kis, et al.
Digital Discovery (2024) Vol. 3, Iss. 9, pp. 1662-1681
Open Access | Times Cited: 4
Scalable mRNA Machine for Regulatory Approval of Variable Scale between 1000 Clinical Doses to 10 Million Manufacturing Scale Doses
Alina Hengelbrock, A. Schmidt, Heribert Helgers, et al.
Processes (2023) Vol. 11, Iss. 3, pp. 745-745
Open Access | Times Cited: 9
Green Manufacturing for Herbal Remedies with Advanced Pharmaceutical Technology
M. Tegtmeier, Larissa Knierim, A. Schmidt, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 188-188
Open Access | Times Cited: 8
Using Peptide Nucleic Acid Hybridization Probes for Qualitative and Quantitative Analysis of Nucleic Acid Therapeutics by Capillary Electrophoresis
Andrei Hutanu, Chiara Signori, Bernd Moritz, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 11, pp. 4914-4922
Open Access | Times Cited: 8
Digital Twin Fundamentals of mRNA In Vitro Transcription in Variable Scale Toward Autonomous Operation
Alina Hengelbrock, A. Schmidt, Jochen Strube
ACS Omega (2024)
Open Access | Times Cited: 2
Using design of experiments to guide genetic optimization of engineered metabolic pathways
S.Y Moon, Anna Saboe, Michael J. Smanski
Journal of Industrial Microbiology & Biotechnology (2024) Vol. 51
Open Access | Times Cited: 2
Formulation of Nucleic Acids by Encapsulation in Lipid Nanoparticles for Continuous Production of mRNA
Alina Hengelbrock, A. Schmidt, Jochen Strube
Processes (2023) Vol. 11, Iss. 6, pp. 1718-1718
Open Access | Times Cited: 5
Aspects and Implementation of Pharmaceutical Quality by Design
Tamás Sovány, Katalin Kristó, Ildikó Csóka
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 832-832
Open Access | Times Cited: 1
Digital Twin for Continuous Production of Virus-like Particles toward Autonomous Operation
Alina Hengelbrock, Finja Probst, Simon Baukmann, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34990-35013
Open Access | Times Cited: 1
Establishment of a Research Focus on Resilient Sustainable Climate Neutral Agricultural Production—Resilient Farming Initiative
Alexander Uhl, A. Schmidt, M. Tegtmeier, et al.
Processes (2023) Vol. 11, Iss. 4, pp. 1105-1105
Open Access | Times Cited: 2
Real‐Time Adaptive Inline Acidification Enhances Continuous pH Control for Viral Inactivation
Jia Sheng Zach Lee, Tan Dai Nguyen, Zi Ying Zheng, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 11
Open Access
RNA Delivery Nanoparticles for Infectious Diseases
Madineh Moradialvand, Parisa Asadollahi
Materials chemistry horizons. (2024) Vol. 3, Iss. 3, pp. 1-14
Open Access
Continuous biomanufacturing in upstream and downstream processing
A. Schmidt, Alina Hengelbrock, Jochen Strube
Physical Sciences Reviews (2023) Vol. 9, Iss. 10, pp. 3167-3222
Closed Access | Times Cited: 1
Chemometric methods in pharmaceutical technology
Jelena Djuriš, Ivana Kurćubić, Svetlana Ibrić, et al.
Elsevier eBooks (2023), pp. 87-124
Closed Access
Biopharma 4.0 for Biologics Manufacturing Under Pandemic Constraints
A. Schmidt, Alina Hengelbrock, Jochen Strube
Cell engineering (2023), pp. 297-317
Closed Access
Page 1

Scroll to top